Sopharma AD sells treasury shares worth BGN 25,625 on Bulgarian Stock Exchange

Ognyan Ivanov Donev Chairman of the Board of Directors and Executive Director Sopharma AD
Ognyan Ivanov Donev Chairman of the Board of Directors and Executive Director - Sopharma AD
0Comments

Sopharma AD has announced the sale of 10,500 treasury shares on August 1, 2025. The transaction took place on the Bulgarian Stock Exchange at an average price of BGN 2.44 per share, totaling BGN 25,625.00. These shares represent approximately 0.002% of the company’s total share capital.

Following this sale, Sopharma AD now holds a total of 26,047,200 treasury shares. This amount accounts for about 4.83% of the company’s overall share capital.

The company made this disclosure in accordance with Article 17 of Regulation (EU) No 596/2014 by the European Parliament and Council.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.